| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/19/2007 | WO2007043623A1 Novel transporter protein in mammal and utilization of the same |
| 04/19/2007 | WO2007043606A1 Antidiabetic agent comprising anionic polyamino acid-metal complex |
| 04/19/2007 | WO2007043531A1 Genetic marker for use in diagnosis of sensitivity to anti-tumor agent or concurrent chemoradiation therapy, and use thereof |
| 04/19/2007 | WO2007043200A1 T cell differentiation controller |
| 04/19/2007 | WO2007043059A1 Process for the preparation of insulin conjugates. |
| 04/19/2007 | WO2007042792A1 Gpr 146 receptor |
| 04/19/2007 | WO2007042778A2 Monitoring cardiovascular disease by determining the expression of kir2ds2 and/or dap12 |
| 04/19/2007 | WO2007042602A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | WO2007042583A1 Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 04/19/2007 | WO2007042524A2 Treating diabetes using inhibitors of il-1 |
| 04/19/2007 | WO2007042487A2 Use of proteins as an antifoaming constituent in fuels |
| 04/19/2007 | WO2007042326A2 Neisseria meningitidis antigens |
| 04/19/2007 | WO2007042309A2 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 04/19/2007 | WO2007042263A1 Antagonists against interaction of pf4 and rantes |
| 04/19/2007 | WO2007042169A2 Matrix metalloproteinase 11 vaccine |
| 04/19/2007 | WO2007042166A2 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 04/19/2007 | WO2007041964A1 The use of long half-life human recombinant soluble tumor necrosis factor alpha receptor in preparing the medicine which can prevent hepatic failure |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007016482A3 Mutant timp-3 |
| 04/19/2007 | WO2007015691A9 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/19/2007 | WO2007010401A3 Glycosylated il-7, preparation and uses |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2007008093A3 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine |
| 04/19/2007 | WO2007002163A3 Production of recombinant selenoprotein mutants with enhanced catalytic activity |
| 04/19/2007 | WO2006134390A3 Method for diagnosing neurodegenerative disease |
| 04/19/2007 | WO2006134195A3 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 04/19/2007 | WO2006130580A3 Mutant il-10 |
| 04/19/2007 | WO2006127948A3 N-terminally modified glp-1 receptor modulators |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006115413A3 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 04/19/2007 | WO2006098849A3 Method and device for detecting feline immunodeficiency virus |
| 04/19/2007 | WO2006089801A8 Method for the redox potential-dependent detection of target molecules by interactive peptides |
| 04/19/2007 | WO2006084642A3 Microorganisms with a disruption of the respiratory chain gene rcs26 for the production of vitamin c |
| 04/19/2007 | WO2006053155A3 Gp202: methods and compositions for treating cancer |
| 04/19/2007 | WO2006029393A8 Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
| 04/19/2007 | WO2006015882A3 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 04/19/2007 | WO2005035712A3 Methods and compositions for infectious cdna of sars coronavirus |
| 04/19/2007 | WO2005021578A3 A novel chimeric polypeptide and use thereof |
| 04/19/2007 | WO2004058189A3 Chemokine antagonists and uses thereof |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | WO2002066614A3 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 04/19/2007 | US20070089202 Use of untranslated region of osmotin gene to enhance transgene expression in plants |
| 04/19/2007 | US20070089197 Papaya ringspot virus genes |
| 04/19/2007 | US20070089180 Transcription factors of cereals |
| 04/19/2007 | US20070089178 Modified Organs and Cells for Xenotransplantation |
| 04/19/2007 | US20070089176 Cytokine involved in epithelial-mesenchymal transition |
| 04/19/2007 | US20070089175 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 04/19/2007 | US20070088156 Recombinant viral-based malaria vaccines |
| 04/19/2007 | US20070088151 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/19/2007 | US20070088150 bacterial surface protein for use in development of vaccines and prevention of bacterial infections |
| 04/19/2007 | US20070087992 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/19/2007 | US20070087990 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 04/19/2007 | US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 04/19/2007 | US20070087961 Conjugates of hydroxyalkyl starch and erythropoietin |
| 04/19/2007 | US20070087959 Method of inducing biomineralization method of inducing bone regeneration and methods related thereof |
| 04/19/2007 | US20070087414 Uses of human Zven proteins and polynucleotides |
| 04/19/2007 | US20070087413 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 04/19/2007 | US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 04/19/2007 | US20070087411 Nucleic acid encoding monomeric fusion polypeptide R1-M-L-M, wherein R1 is a ligand-binding domain of an interleukin receptor capable of binding an interleukin target ligand, M is a self-associating component, and L is a linker; therapy for cancer or diabetic retinopathy |
| 04/19/2007 | US20070087407 Hepatitis C receptor protein CD81 |
| 04/19/2007 | US20070087406 Isoforms of receptor for advanced glycation end products (RAGE) and methods of identifying and using same |
| 04/19/2007 | US20070087405 A recombinant insect cell, especially Trichoplusia ni or Drosophila melanogaster, comprising a transfected gene encoding prolyl 4-hydroxylase |
| 04/19/2007 | US20070087390 Opiate, cannabinoid, and estrogen receptors |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087384 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders. |
| 04/19/2007 | US20070087380 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 04/19/2007 | US20070087379 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs |
| 04/19/2007 | US20070087378 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 04/19/2007 | US20070087374 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087373 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087371 Zinc finger domains and methods of identifying same |
| 04/19/2007 | US20070087351 Orotate transporter encoding maker genes |
| 04/19/2007 | US20070087347 Dose-dependent promoter originating in humans |
| 04/19/2007 | US20070087346 Orthogonal gene switches |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087039 Methods of increasing bone density/preventing osteoporosis, of reducing joint pain and/or joint deterioration from osteoarthritis, degenerative joint disease, joint defect, and rheumatoid arthritis; maximum and consistent bioavailability |
| 04/19/2007 | US20070087024 Article comprising fibers embedded in a glassy protein |
| 04/19/2007 | US20070087019 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/19/2007 | US20070087018 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/19/2007 | US20070087017 Ultrafiltration for preparing outer membrane vesicles |
| 04/19/2007 | US20070087014 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 04/19/2007 | US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 04/19/2007 | US20070087007 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/19/2007 | US20070087003 Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof |
| 04/19/2007 | US20070086997 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 04/19/2007 | US20070086980 Methods of treating cancer using il-21 |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | DE10248141B4 Nukleinsäuren und deren Verwendung für die Gentherapie Nucleic acids and their use for gene therapy |
| 04/19/2007 | DE102006001773B3 Preparation of a molded protein composite comprises dispersing the protein in water and in aqueous solution of ionic liquid, applying the solution on a smooth plate and recovering the molded protein composite as foil/membrane |
| 04/19/2007 | DE102005048898A1 EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen EGLN2 variants and their use in the prevention or treatment of thromboembolic diseases and coronary heart disease |
| 04/19/2007 | DE102005048828A1 New light, oxygen, voltage domains, and proteins containing them, useful as fluorescent markers, e.g. in gene therapy, cloning and cell sorting, are altered to prevent covalent bonding to flavine mononucleotide |
| 04/19/2007 | DE102005048720A1 Verwendung von Proteinen als Antischaum-Komponente in Kraftstoffen Use of proteins as antifoam component in fuels |
| 04/19/2007 | CA2648649A1 Antagonists against interaction of pf4 and rantes |
| 04/19/2007 | CA2625993A1 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation |
| 04/19/2007 | CA2625613A1 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 04/19/2007 | CA2625506A1 Immuno-stimulant combination for prophylaxis and treatment of hepatitis c |
| 04/19/2007 | CA2625436A1 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| 04/19/2007 | CA2625395A1 Vegf analogs and methods of use |